Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
CEOP-R regimen
Introduction
Synonyms and keywords: R-CEOP; Rituximab/Cyclophosphamide/Epirubicin/Vincristine/Prednisone
Overview
Overview
CEOP-R regimen refers to an immunochemotherapy regimen consisting of cyclophosphamide, epirubicin, vincristine (Oncovin), prednisone and rituximab used to treat both indolent and aggressive forms of Diffuse large B-cell lymphoma.[1]
Regimen
Regimen
CCyclophosphamide
EEpirubicin
OVincristine (Oncovin)
PPrednisone
RRituximab
References
References
- ↑ 1.0 1.1 Li Y, Yimamu M, Wang X, Zhang X, Mao M, Fu L; et al. (2014). “Addition of rituximab to a CEOP regimen improved the outcome in the treatment of non-germinal center immunophenotype diffuse large B cell lymphoma cells with high Bcl-2 expression”. Int J Hematol. 99 (1): 79–86. doi:10.1007/s12185-013-1472-z. PMID 24258714.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]